CI vs SLRX · P/E 2.4, rev $274.90B vs $4.9M cap
Cigna Corp (CI) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the CI and SLRX stock pages for the full models.
Not investment advice.